Ovatech™ reports successful completion of Phase 2 clinical trial of Ovaprene™ non-horInformation on Ovatech™ reports successful completion of Phase 2 clinical trial of Ovaprene™ non-hor under Hormonal section of the Health Articles & Reviews; AUBURNDALE, Mass.--(BUSINESS WIRE)--Ovatech, an emerging women’s health-focused company, announced today that the Company’s Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has ... |
![]() |
|
Ovatech™ reports successful completion of Phase 2 clinical trial of Ovaprene™ non-hor
by Haddasah_Milovsky 08-31-2010, 06:43 PM
AUBURNDALE, Mass.--(BUSINESS WIRE)--Ovatech, an emerging women’s health-focused company, announced today that the Company’s Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a ‘one-size-fits-all’ patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously ...
More... |
|
Views 19
Comments 0
|
![]() |
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |